7-42934975-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_031903.3(MRPL32):c.151G>A(p.Gly51Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000124 in 1,611,286 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_031903.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MRPL32 | NM_031903.3 | c.151G>A | p.Gly51Ser | missense_variant | 2/3 | ENST00000223324.3 | NP_114109.1 | |
MRPL32 | NR_156497.1 | n.162G>A | non_coding_transcript_exon_variant | 2/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MRPL32 | ENST00000223324.3 | c.151G>A | p.Gly51Ser | missense_variant | 2/3 | 1 | NM_031903.3 | ENSP00000223324 | P1 | |
MRPL32 | ENST00000432845.1 | c.151G>A | p.Gly51Ser | missense_variant, NMD_transcript_variant | 2/3 | 2 | ENSP00000415581 | |||
MRPL32 | ENST00000413995.1 | upstream_gene_variant | 2 | ENSP00000391562 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152124Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000402 AC: 1AN: 248770Hom.: 0 AF XY: 0.00000743 AC XY: 1AN XY: 134504
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1459162Hom.: 0 Cov.: 31 AF XY: 0.0000179 AC XY: 13AN XY: 725854
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152124Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74312
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 12, 2022 | The c.151G>A (p.G51S) alteration is located in exon 2 (coding exon 2) of the MRPL32 gene. This alteration results from a G to A substitution at nucleotide position 151, causing the glycine (G) at amino acid position 51 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at